Pneumonia in children
343 results
1 - 100
Pneumonia in children 
Chest physiotherapy for pneumonia in children- Antibiotics for community‐acquired pneumonia in children
GERD tx in children assoc with pneumonia risk- Vitamin A for non‐measles pneumonia in children
- Antibiotics for hospital‐acquired pneumonia in neonates and children
- Comparison of different antibiotics for community acquired pneumonia in children
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Low rate of bacteremia in children hospitalized with pneumonia
- Clinical signs and symptoms of pneumonia unreliable in children
- Serum procalcitonin not very accurate in diagnosing children with pneumonia
- Evidence does not show benefit of treating mycoplasma pneumonia in children
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
- Lung ultrasound reduces need for CXR in children with suspected pneumonia
- Scores based on bedside clinical findings are helpful in identifying pneumonia in febrile children
- Useful signs and symptoms for diagnosing pneumonia in children younger than 5 years
- Reliability of some clinical exam findings is dubious in children with suspected pneumonia
- Three days of amoxicillin is effective for pneumonia with tachypnea in young children
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Five days of antibiotic therapy is comparable with 10 days in children with community-acquired pneumonia (SAFER)
- Over‐the‐counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children under two years of age
- Comparable outcomes with 5 days and 10 days of antibiotics in children with community-acquired pneumonia (SCOUT-CAP)
- Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age
- Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
- Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
- Short-course versus long-course antibiotic therapy for (by WHO algorithm) non-severe community-acquired pneumonia in children aged 2 months to 59 months in developing countries